Antibody targeting of claudin-1 as a potential colorectal cancer therapy

od Cherradi, S., Ayrolles-Torro, A., Vezzo-Vié, N., Gueguinou, N., Denis, V., Combes, E., Boissière, F., Busson, M., Canterel-Thouennon, L., Mollevi, C., Pugnière, M., Bibeau, F., Ychou, M., Martineau, P., Gongora, C., Del Rio, M.
Wydane w J Exp Clin Cancer Res (2017)

FOXO3a and the MAPK p38 are activated by cetuximab to induce cell death and inhibit cell proliferation and their expression predicts cetuximab efficacy in colorectal cancer

od Marzi, L, Combes, E, Vié, N, Ayrolles-Torro, A, Tosi, D, Desigaud, D, Perez-Gracia, E, Larbouret, C, Montagut, C, Iglesias, M, Jarlier, M, Denis, V, Linares, L K, Lam, E W-F, Martineau, P, Del Rio, M, Gongora, C
Wydane w Br J Cancer (2016)